Deutsche Bank
PBYI icon

Deutsche Bank’s Puma Biotechnology PBYI Stock Holding History

Deutsche Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-393
Closed -$45K – 5295
2015
Q2 		$45K Buy
+393
New +$71.2K ﹤0.01% 4637

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's PBYI Position: Q2 2026 in Review

Deutsche Bank increased its Puma Biotechnology (PBYI) stake by 30% in Q2 2026, buying an estimated $73.6K and bringing the position to 43,192 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

Deutsche Bank first reported a position in PBYI in Q2 2013 and has held it in 41 quarters since. The position peaked at $72.3M in Q3 2017. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Deutsche Bank held 43,192 shares of Puma Biotechnology worth $350K as of Q2 2026.
  • Deutsche Bank bought 10,047 Puma Biotechnology shares in Q2 2026, an estimated $73.6K.
  • Puma Biotechnology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2959 holding.
  • Deutsche Bank first reported a position in Puma Biotechnology in Q2 2013 and has held it in 41 quarters since.
  • Deutsche Bank's Puma Biotechnology position peaked at $72.3M in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.